http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1525425-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 |
| filingDate | 1976-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1978-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1525425-A |
| titleOfInvention | Sustained release forms of certain oxazepines |
| abstract | 1525425 Injectable compositions of oxazepine derivatives AMERICAN CYANAMID CO 28 June 1976 [16 July 1975] 26914/76 Heading A5B Injectable compositions having antidepressant and antipsychotic activity and a sustained action comprise the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz [b, f,] [1, 4] oxazepine or of 2-chloro-11-(4-methyl-1- piperazinyl)-dibenz [b, f,] [1, 4] oxazepine, in an injectable oil at a concentration of 50-400 mg./ml., and a gelling agent (e.g. aluminium mono stearate) at a concentration of 10-100 mg./ml. |
| priorityDate | 1975-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.